EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster
On May 23, AstraZeneca said its new crown vaccine Vaxzevria had been approved by the European Medicines Agency (EMA) as a booster vaccine for adults. Last Thursday, AstraZeneca's new crown vaccine booster (clinical trial data) received a positive assessment from the CHMP (European Committee for Medicinal Products for Human Use).
It is reported that the vaccine can be used as a booster for the first two doses of the Vaxzevria new crown vaccine, and can also be used as a booster for other mRNA new crown vaccines produced by companies such as Pfizer (PFE.US)/BioNTech (BNTX.US) or Moderna (MRNA.US). Strengthen the needle.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
AstraZeneca and CSPC Strengthen Biologics Manufacturing Partnership in China
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
$15 Billion Invested in China: AstraZeneca Builds an “Innovation Hub” While Some Are Still Waiting for the Windfall
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
AstraZeneca to Invest $2.5 Billion to Establish Global Drug R&D Center in Beijing
-
AstraZeneca to invest $3.5 billion in the United States
-
Ascending to the Summit: AstraZeneca Crowned as the Most Competitive MNC in China
-
Restructuring at AstraZeneca China: Leadership Changes and New Business Division
-
Bristol Myers Squibb's Acquisition Spree: Will it Boost its Cancer Drug Portfolio?
Recommend Reading
-
![Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A]()
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
![AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale]()
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
![Iran Conflict Leaves a Long Shadow on Drug Supply]()
Iran Conflict Leaves a Long Shadow on Drug Supply
-
![Bayer Wins Big on Roundup]()
Bayer Wins Big on Roundup
-
![Syngenta Gets a New Boss]()
Syngenta Gets a New Boss
-
![BDO Market Trend Consolidation and Operation]()
BDO Market Trend Consolidation and Operation
-
![Business Society October 16, 2026 Styrene Trend Analysis: Volatile with a Slight Bullish Bias]()
Business Society October 16, 2026 Styrene Trend Analysis: Volatile with a Slight Bullish Bias
-
![Phosphate prices weakened and fell in the first week of July in China (7.1-7.7)]()
Phosphate prices weakened and fell in the first week of July in China (7.1-7.7)
-
![Business Society October 16, 2026 Caustic Soda Trend Analysis: Volatile Trading]()
Business Society October 16, 2026 Caustic Soda Trend Analysis: Volatile Trading
-
![Geopolitical Conflicts and Tightening Inventories Push Oil Market Up 3% on Tuesday]()
Geopolitical Conflicts and Tightening Inventories Push Oil Market Up 3% on Tuesday
